Growth Metrics

OptimizeRx (OPRX) Share-based Compensation (2016 - 2026)

OptimizeRx's Share-based Compensation history spans 14 years, with the latest figure at $2.0 million for Q4 2025.

  • On a quarterly basis, Share-based Compensation fell 33.27% to $2.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.0 million, a 39.29% decrease, with the full-year FY2025 number at $7.0 million, down 39.29% from a year prior.
  • Share-based Compensation hit $2.0 million in Q4 2025 for OptimizeRx, roughly flat from $2.0 million in the prior quarter.
  • Over the last five years, Share-based Compensation for OPRX hit a ceiling of $13.2 million in Q4 2023 and a floor of -$7.3 million in Q3 2023.
  • Historically, Share-based Compensation has averaged $2.7 million across 5 years, with a median of $2.8 million in 2024.
  • Biggest five-year swings in Share-based Compensation: soared 538.78% in 2022 and later crashed 271.68% in 2023.
  • Tracing OPRX's Share-based Compensation over 5 years: stood at $3.1 million in 2021, then surged by 36.4% to $4.3 million in 2022, then soared by 208.63% to $13.2 million in 2023, then crashed by 77.71% to $2.9 million in 2024, then plummeted by 33.27% to $2.0 million in 2025.
  • Business Quant data shows Share-based Compensation for OPRX at $2.0 million in Q4 2025, $2.0 million in Q3 2025, and $1.5 million in Q2 2025.